Search Results

Safety and efficacy of long-term use of a buprenorphine transdermal patch system in patients with osteoarthritis and low back pain refractory to non-opioid analgesics: Post-marketing surveillance of 3000 cases.

• Authors : Ushida T; Aichi Medical University, Nagakute-shi, Aichi, Japan.; Kanzaki R

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/administration & dosage ; Buprenorphine*/Buprenorphine*/Buprenorphine*/adverse effects ; Transdermal Patch*

• Source: Pain practice : the official journal of World Institute of Pain [Pain Pract] 2025 Jan; Vol. 25 (1), pp. e13430. Date of Electronic Publication: 2024 Oct 21.Publisher: Blackwell Science, Inc Country of Publication: United States NLM ID: 101130835 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms.

• Authors : Takekita Y; Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.; Matsumoto Y

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Transdermal Patch* ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/administration & dosage

• Source: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Dec; Vol. 44 (4), pp. 784-791. Date of Electronic Publication: 2024 Oct 20.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Transdermal patch

• Source: Funk & Wagnalls New World Encyclopedia. 2018, 1p.

Record details

Reliability of urine drug testing among patients on buprenorphine transdermal patch.

• Authors : Amaram-Davila J; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reddy A

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Buprenorphine*/Buprenorphine*/Buprenorphine*/pharmacology ; Analgesics, Opioid*/Analgesics, Opioid*/Analgesics, Opioid*/therapeutic use

• Source: Palliative & supportive care [Palliat Support Care] 2024 Aug; Vol. 22 (4), pp. 822-824.Publisher: Cambridge University Press Country of Publication: England NLM ID: 101232529 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Severe behavioral and psychological symptoms of dementia successfully treated at home with a blonanserin transdermal patch: A case report.

• Authors : Yamaguchi J; Asakusa Family Clinic, Tokyo, Japan.; Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan.

Subjects: Piperidines*/Piperidines*/Piperidines*/administration & dosage ; Piperidines*/Piperidines*/Piperidines*/adverse effects ; Transdermal Patch*

• Source: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Jun; Vol. 44 (2), pp. 474-478. Date of Electronic Publication: 2024 Apr 01.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Fabrication, evaluation, and enhanced penetration of vinyl and cellulose-engineered transdermal patch of nifedipine using essential oil as penetration enhancer.

• Authors : Das S; Department of Pharmaceutical Technology, Brainware University, Barasat, India.; Department of Pharmaceutics, Himalayan Pharmacy Institute, Majhitar, India.

Subjects: Nifedipine*/Nifedipine*/Nifedipine*/pharmacokinetics ; Nifedipine*/Nifedipine*/Nifedipine*/administration & dosage ; Nifedipine*/Nifedipine*/Nifedipine*/chemistry

• Source: Journal of biomaterials science. Polymer edition [J Biomater Sci Polym Ed] 2024 Jun; Vol. 35 (9), pp. 1400-1420. Date of Electronic Publication: 2024 Mar 19.Publisher: Taylor and Francis Country of Publication: England NLM ID: 9007393 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo.

• Authors : Chu PC; Department of Chemistry, National Chung Hsing University, Taichung, Taiwan.; Basic Research and Development Department, Powin Biomedical Co. Ltd., Taichung, Taiwan.

Subjects: Cannabidiol*/Cannabidiol*/Cannabidiol*/pharmacokinetics ; Cannabidiol*/Cannabidiol*/Cannabidiol*/chemistry ; Cannabidiol*/Cannabidiol*/Cannabidiol*/administration & dosage

• Source: International journal of nanomedicine [Int J Nanomedicine] 2024 May 16; Vol. 19, pp. 4321-4337. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Design, fabrication, and evaluation of keratin and pectin incorporated supramolecular structured zero-oxidation state selenium nanogel blended 3D printed transdermal patch.

• Authors : Baburao C; Department of Biotechnology, Pondicherry University, Kalapet, Puducherry, India.; Selvasudha N

Subjects: Selenium*/Selenium*/Selenium*/chemistry ; Pectins*/Pectins*/Pectins*/chemistry ; Transdermal Patch*

• Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 May; Vol. 268 (Pt 1), pp. 131769. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Acceptability of antipsychotic transdermal patch for acute schizophrenia: a systematic review and meta-analysis.

• Authors : Kishi T; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.; Citrome L

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/administration & dosage ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects

• Source: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2024 Apr; Vol. 78 (4), pp. 260-262. Date of Electronic Publication: 2024 Jan 28.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Rhamnose-PEG-induced supramolecular helices: Addressing challenges of drug solubility and release efficiency in transdermal patch.

• Authors : Song H; Department of Pharmaceutical Sciences, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.; Liu C

Subjects: Rhamnose* ; Transdermal Patch*; Pharmaceutical Preparations

• Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Mar; Vol. 367, pp. 848-863. Date of Electronic Publication: 2024 Feb 16.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details